HDAC Inhibitor Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action ...
DelveInsight’s, “HDAC Inhibitor Pipeline Insight” report provides comprehensive insights about 40+ companies and 50+ pipeline ...
The American Journal of Managed Care13 天
Emerging Therapies Shine Hope on Small Cell Lung Cancer Treatment
Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...
The Brighterside of News on MSN19 天
Dietary choices significantly impact gene function and overall health
Short-chain fatty acids (SCFAs) like propionate and butyrate are critical byproducts of dietary fiber digestion. These molecules do more than fuel the body—they directly influence gene expression and ...
BioWorld6 天
TMP-269 prevents neuronal damage in PD models
Researchers from the University College Cork have described the neuroprotective effect of TMP-269, a class-IIa-specific histone deacetylase (HDAC) inhibitor in preclinical models of PD. Pan-inhibitors ...
来自MSN1 个月
'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link
(UC San Diego) Viracta Therapeutics announced the closure of a phase II trial of its combination therapy of the histone deacetylase inhibitor nanatinostat and the antiviral agent valganciclovir ...